Cell- and Molecular-Mediated Drug Delivery for Bone and Cartilage Repair
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: closed (30 September 2025) | Viewed by 566
Special Issue Editors
2. Hospital Sírio Libanês, Sao Paulo, Brazil
Interests: bone defects; orthopaedic biologics; cell therapy; tissue engineering; dentistry; cleft lip and palate
Special Issues, Collections and Topics in MDPI journals
2. Department of Metallurgical and Materials Engineering, The University of São Paulo, Sao Paulo, Brazil
Interests: osteoarthritis; cartilage repair; orthopaedic biologics; cell therapy; tissue engineering; orthopaedics; sports medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue on "Cell- and Molecular-Mediated Drug Delivery for Bone and Cartilage Repair".
Bone and cartilage injuries represent a significant clinical challenge, remaining a major hurdle in the effective treatment and improvement of patients' clinical outcomes.
Cellular and molecular approaches in drug delivery hold tremendous potential to enhance tissue repair, reduce side effects, and improve patient outcomes. Recent advancements in drug delivery systems have revolutionized treatment strategies, offering targeted, efficient, and sustained therapeutic effects.
We look forward to receiving your contributions.
Dr. Tiago Lazzaretti Fernandes
Dr. Daniela Franco Bueno
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery systems
- drug discovery
- bone repair
- cartilage repair
- molecular therapies
- cellular approaches
- tissue engineering
- nanotechnology
- stem cell therapy
- biomaterials
- osteoarthritis
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
